Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:47 PM
Ignite Modification Date:
2025-12-24 @ 1:47 PM
NCT ID:
NCT00444795
Brief Summary:
To monitor use in real practice including adverse events and efficacy on Sutent capsules (Sunitinib malate)
Detailed Description:
All the patients prescribed according to approved indications at contracted institutions
Study:
NCT00444795
Study Brief:
Protocol Section:
NCT00444795